{
  "pmid": "18502337",
  "uid": "18502337",
  "title": "An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer.",
  "abstract": "Radioactive iodine remnant ablation (RRA) is used to destroy residual normal thyroid tissue after complete gross surgical resection of papillary or follicular thyroid cancer. The article updates a prior systematic review of the literature to determine whether RRA decreases the risk of thyroid cancer-related death or recurrence at 10 years after initial surgery, including data from 28 studies. No long-term randomized trials were identified, so the review is limited to observational studies. The incremental benefit of RRA in low risk patients with well-differentiated thyroid cancer after total or near-total thyroidectomy who are receiving thyroid hormone suppressive therapy remains unclear.",
  "authors": [
    {
      "last_name": "Sawka",
      "fore_name": "Anna M",
      "initials": "AM",
      "name": "Anna M Sawka",
      "affiliations": [
        "Department of Medicine, Division of Endocrinology, University Health Network, Toronto, ON, Canada. sawkaam@yahoo.com"
      ]
    },
    {
      "last_name": "Brierley",
      "fore_name": "James D",
      "initials": "JD",
      "name": "James D Brierley",
      "affiliations": []
    },
    {
      "last_name": "Tsang",
      "fore_name": "Richard W",
      "initials": "RW",
      "name": "Richard W Tsang",
      "affiliations": []
    },
    {
      "last_name": "Thabane",
      "fore_name": "Lehana",
      "initials": "L",
      "name": "Lehana Thabane",
      "affiliations": []
    },
    {
      "last_name": "Rotstein",
      "fore_name": "Lorne",
      "initials": "L",
      "name": "Lorne Rotstein",
      "affiliations": []
    },
    {
      "last_name": "Gafni",
      "fore_name": "Amiram",
      "initials": "A",
      "name": "Amiram Gafni",
      "affiliations": []
    },
    {
      "last_name": "Straus",
      "fore_name": "Sharon",
      "initials": "S",
      "name": "Sharon Straus",
      "affiliations": []
    },
    {
      "last_name": "Goldstein",
      "fore_name": "David P",
      "initials": "DP",
      "name": "David P Goldstein",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Endocrinology and metabolism clinics of North America",
    "iso_abbreviation": "Endocrinol Metab Clin North Am",
    "issn": "0889-8529",
    "issn_type": "Print",
    "volume": "37",
    "issue": "2",
    "pub_year": "2008",
    "pub_month": "Jun"
  },
  "start_page": "457",
  "end_page": "x",
  "pages": "457-80, x",
  "language": "eng",
  "publication_types": [
    "Evaluation Study",
    "Journal Article",
    "Research Support, Non-U.S. Gov't",
    "Systematic Review"
  ],
  "keywords": [
    "Carcinoma, Papillary",
    "Carcinoma, Papillary, Follicular",
    "Disease Progression",
    "Humans",
    "Iodine Radioisotopes",
    "Neoplasm Recurrence, Local",
    "Neoplasm, Residual",
    "Radiotherapy, Adjuvant",
    "Thyroid Neoplasms",
    "Thyroidectomy",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "18502337",
    "doi": "10.1016/j.ecl.2008.02.007",
    "pii": "S0889-8529(08)00011-X"
  },
  "doi": "10.1016/j.ecl.2008.02.007",
  "dates": {
    "completed": "2008-08-18",
    "revised": "2025-06-23"
  },
  "chemicals": [
    "Iodine Radioisotopes"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:21:44.876943",
    "pmid": "18502337"
  }
}